Acquisitions and Divestitures - Additional Information (Detail) $ in Thousands |
|
1 Months Ended |
3 Months Ended |
12 Months Ended |
|
|
|
Nov. 30, 2014
USD ($)
|
Aug. 31, 2015
USD ($)
|
Jul. 31, 2015
USD ($)
|
May. 31, 2015
USD ($)
Agreement
|
Oct. 31, 2014
USD ($)
|
Sep. 30, 2014
USD ($)
|
Aug. 31, 2014
USD ($)
|
Aug. 31, 2013
USD ($)
|
Jul. 31, 2013
USD ($)
|
Oct. 31, 2012
USD ($)
|
Sep. 30, 2015
USD ($)
|
Dec. 31, 2015
USD ($)
|
Dec. 31, 2014
USD ($)
|
Dec. 31, 2013
USD ($)
|
Oct. 31, 2013
USD ($)
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average useful life |
|
|
|
|
|
|
|
|
|
|
|
6 years
|
|
|
|
| Goodwill |
|
|
|
|
|
|
|
|
|
|
|
$ 17,789
|
$ 17,281
|
$ 15,031
|
|
| Gain on divestiture |
|
|
|
|
|
|
|
|
|
|
|
$ 360
|
|
|
|
| Impairment charges |
|
|
|
|
|
|
|
|
|
|
|
|
229
|
|
|
| Non-Occlusive Modeling Catheter Divestiture [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Impairment charges |
|
|
|
|
|
|
|
|
|
|
|
|
200
|
|
|
| Charge to cost of sales |
|
|
|
|
|
|
|
|
|
|
|
|
300
|
|
|
| Merit Medical Ireland Limited [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Asset sales agreement amount |
|
|
$ 400
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gain on divestiture |
|
|
|
|
|
|
|
|
|
|
$ 400
|
|
|
|
|
| XenoSure [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase price for acquisition of assets and rights |
|
|
|
|
|
|
|
|
|
$ 4,600
|
|
|
|
|
|
| Cash paid for assets purchased |
|
|
|
|
|
|
|
|
|
4,300
|
|
|
|
|
|
| Cash paid for manufacturing and distribution rights |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 300
|
| Intangible assets |
|
|
|
|
|
|
|
|
|
2,800
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
|
|
|
|
$ 1,800
|
|
|
|
|
|
| Maximum goodwill deductible for tax purposes |
|
|
|
|
|
|
|
|
|
|
|
15 years
|
|
|
|
| Weighted average useful life |
|
|
|
|
|
|
|
|
|
|
|
12 years
|
|
|
|
| XenoSure [Member] | Non-Compete Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Acquisition date of assets and rights |
|
|
|
|
|
|
|
|
|
|
|
Oct. 31, 2012
|
|
|
|
| Clinical Instruments International, Inc [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase price for acquisition of assets and rights |
|
|
|
|
|
|
|
|
$ 1,100
|
|
|
|
|
|
|
| Acquisition date of assets and rights |
|
|
|
|
|
|
|
|
|
|
|
Jul. 30, 2013
|
|
|
|
| Cash paid for assets purchased |
|
|
|
|
$ 200
|
|
|
|
900
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
|
|
300
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
|
|
|
600
|
|
|
|
|
|
|
| Maximum goodwill deductible for tax purposes |
|
|
|
|
|
|
|
|
|
|
|
15 years
|
|
|
|
| Weighted average useful life |
|
|
|
|
|
|
|
|
|
|
|
5 years 8 months 12 days
|
|
|
|
| Inventory |
|
|
|
|
|
|
|
|
$ 200
|
|
|
|
|
|
|
| InaVein LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase price for acquisition of assets and rights |
|
|
|
|
|
|
|
$ 2,500
|
|
|
|
|
|
|
|
| Acquisition date of assets and rights |
|
|
|
|
|
|
|
|
|
|
|
Aug. 30, 2013
|
|
|
|
| Cash paid for assets purchased |
|
|
|
|
|
$ 400
|
|
2,100
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
|
1,143
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
|
|
$ 700
|
|
|
|
|
|
|
|
| Maximum goodwill deductible for tax purposes |
|
|
|
|
|
|
|
15 years
|
|
|
|
|
|
|
|
| Acquisition-related contingent consideration |
|
|
|
|
|
|
|
$ 1,400
|
|
|
|
|
|
|
|
| Fair value of contingent consideration |
|
|
|
|
|
|
$ 100
|
|
|
|
|
|
|
|
|
| Assumed liabilities |
|
|
|
|
$ 200
|
|
|
100
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
|
|
668
|
|
|
|
|
|
|
|
| InaVein LLC [Member] | Non-Compete Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
|
$ 70
|
|
|
|
|
|
|
|
| Weighted average useful life |
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
| Xenotis Pty Ltd [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase price for acquisition of assets and rights |
|
|
|
|
|
|
6,700
|
|
|
|
|
|
|
|
|
| Acquisition date of assets and rights |
|
|
|
|
|
|
|
|
|
|
|
Aug. 31, 2014
|
|
|
|
| Cash paid for assets purchased |
|
$ 1,400
|
|
|
|
|
5,100
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
1,794
|
|
|
|
|
|
|
|
|
| Assumed liabilities |
|
|
|
|
|
|
1,731
|
|
|
|
|
|
|
|
|
| Adjustment to tangible asset acquired |
$ 200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business acquisition, assumed debt |
|
|
|
|
|
|
1,100
|
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
|
2,475
|
|
|
|
|
|
|
|
|
| Deferred tax assets acquired |
|
|
|
|
|
|
2,400
|
|
|
|
|
|
|
|
|
| Xenotis Pty Ltd [Member] | Non-Compete Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
$ 135
|
|
|
|
|
|
|
|
|
| Weighted average useful life |
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
| Xenotis Pty Ltd [Member] | Europe [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase price for acquisition of assets and rights |
|
|
|
|
|
$ 1,300
|
|
|
|
|
|
|
|
|
|
| Cash paid for assets purchased |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,100
|
|
|
| Intangible assets |
|
|
|
|
|
|
|
|
|
|
|
$ 900
|
|
|
|
| Weighted average useful life |
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
| Inventory |
|
|
|
|
|
|
|
|
|
|
|
$ 400
|
|
|
|
| AngioScope [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase price for acquisition of assets and rights |
|
|
|
|
|
$ 400
|
|
|
|
|
|
|
|
|
|
| Cash paid for assets purchased |
|
|
|
|
|
300
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
276
|
|
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
$ 100
|
|
|
|
|
|
|
|
|
|
| Maximum goodwill deductible for tax purposes |
|
|
|
|
|
15 years
|
|
|
|
|
|
|
|
|
|
| Inventory |
|
|
|
|
|
$ 26
|
|
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
80
|
|
|
|
|
|
|
|
|
|
| Balance payable to Clinical Instruments |
|
|
|
|
|
100
|
|
|
|
|
|
|
|
|
|
| AngioScope [Member] | Non-Compete Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
$ 3
|
|
|
|
|
|
|
|
|
|
| Weighted average useful life |
|
|
|
|
|
2 years
|
|
|
|
|
|
|
|
|
|
| Tru-Incise Valvulotome [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase price for acquisition of assets and rights |
|
|
|
$ 1,400
|
|
|
|
|
|
|
|
|
|
|
|
| Acquisition date of assets and rights |
|
|
|
|
|
|
|
|
|
|
|
May 31, 2015
|
|
|
|
| Cash paid for assets purchased |
|
|
|
1,100
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
545
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum goodwill deductible for tax purposes |
|
|
|
|
|
|
|
|
|
|
|
|
15 years
|
|
|
| Inventory |
|
|
|
88
|
|
|
|
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
742
|
|
|
|
|
|
|
|
|
|
|
|
| Balance payable to Clinical Instruments |
|
|
|
300
|
|
|
|
|
|
|
|
|
|
|
|
| Tru-Incise Valvulotome [Member] | Non-Compete Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
$ 120
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average useful life |
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
| UreSil, LLC, Distributors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase price for acquisition of assets and rights |
|
|
|
$ 200
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
$ 200
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average useful life |
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
| Number of definitive agreements | Agreement |
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
| Grex Medical Oy [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase price for acquisition of assets and rights |
|
$ 200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Acquisition date of assets and rights |
|
|
|
|
|
|
|
|
|
|
|
Jan. 01, 2016
|
|
|
|